serum ph activity was measured in patients with primary myelofibrosis ( agnogenic myeloid metaplasia and myelofibrosis with prior history of polycythaemia vera ) , in patients with secondary myelofibrosis ( in association with carcinoma metastasis ) , in patients with other myeloproliferative disorders and in controls ( anaemia patients and normal volunteers ) .
C0001815
myelofibrosis
C0027022
myeloproliferative disorders